Abstract
Despite a higher risk of toxicity in elderly pts treated with chemotherapy, the impact of chemotherapy on quality of life in this pt subgroup has not been extensively studied. We aimed to evaluate the impact of docetaxel on QoL in elderly vs non-elderly mCRPC pts.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
